In this episode of Truth in Transformation, host Paul Abramowitz, ASHP CEO, talks with  ASHP President Tom Johnson about how transformation can create new  opportunities. As an innovator in safe medication use, best practices,  accreditation services, professional development, and continuing education,  ASHP is a leader in transforming pharmacy practice to meet the demands of a  dynamic evolving profession. 
Paul  Abramowitz (00:02): I’m your host, Paul  Abramowitz, the CEO of ASHP, and with me is ASHP President Tom Johnson. During  this series of podcasts, we've explored many different aspects of  transformation from servant leadership to transforming our pharmacy presence.  Today, we'll be talking about transformation as a necessary step in the  advancement of the profession—how transformation can create new opportunities  in our evolving profession. 
Tom  Johnson: That's where we're at Paul. We're down  to how do we really get to transformation? In my inaugural, I talked about  transformation being more than change, just doing something a little bit  different. And I will say that after writing this inaugural, and I've been  listening to a handful of leadership books lately, and re-read another one—I  tend to go in spurts from fiction to nonfiction, to leadership, to whatever. I  think I've said before, I'm an audible listener. That's how I consume a lot of  books. It works pretty well for me.
I've started listening for the key  concepts of transformation. The key concepts show up in leadership books, they  show up in marketing books, they show up in how to adjust your mindset. The key  thing of human nature is that people actually strive to be transformed. I think  that's a pretty cool message. 
I've been in the profession now better  part of 25 years and a little more than that from when I first set foot in  pharmacy school. We've been talking about a lot of the same things. We've come  a long way in 25 years, but I think ultimately we just need to continue to  think about how do we keep working our way forward? How do we be present? How  do we tell other people about our presence? How do we transform?
The pharmacy profession has had some  really good successes lately. We have essentially transformed in the last  several months, not only through COVID and everything else going on, but right  about the time COVID was hitting in March, there was a release of how to dose  vancomycin. That’s a transformation I've seen the profession adopt. I've seen  our own pharmacists come up with new ways of looking at this. I think it's a  great example of how we can transform, understand the why, and then move  forward. 
Paul  Abramowitz (03:19): Well, 2020 has been  a year like no other, and we talked a little bit about this in our last  podcast, but let's take a step back for a minute. Along the lines of what you  mentioned with vancomycin, being a change, being stimulated by what was going  on in the environment, let's talk a little bit more about how crisis can bring  about opportunities. Set the stage for our conversation today. 
Tom  Johnson (03:48): I think forced change  can really reveal some new options. It removes some barriers to change. We  talked a little bit about change management last time and change is going to be  resisted. 
One of the things I say, sort of tongue  in cheek, to illustrate that point, is remember change is bad and should be  resisted at all possible opportunity.  I  say that jokingly, but it helps understand sort of this mindset and it gets  people sort of laughing.  We do resist  change because we're comfortable and we want to do things that way. 
Sometimes forced opportunities can  reveal quite a few things. For example, we have been virtual; everything lately  at ASHP has been converted to virtual.  Everybody's  working from home and doing a lot of different things. The board is meeting on  a virtual basis. Our section is met on a virtual basis. The House of Delegates  was done virtually. 
Would it have been our choice to do  that? Probably not, but we have found some efficiencies. I'd like you to talk a  little bit about the great work that the ASAP staff has done to really pivot  the last six months. I see it as a board member and as president. I get a  chance to work with you and the staff a lot, but I don't think the average  member listening to this has that opportunity.
I'd like to give you a chance to talk a  little bit about the great work that ASHP staff has been doing these last  several months. 
Paul  Abramowitz (05:29): Well, thank you, Tom. I would just like  to say that ASHP is definitely the most forward-thinking and effective pharmacy  organization. That's backed up by the fact that our membership has been  increasing by a very rapid rate of numbers, of pharmacist, student pharmacist,  pharmacy technicians, and the like. We've greatly expanded in response to our  members, requests, the education and information, and services that we provide  specifically since the COVID-19 pandemic has occurred. 
And we've started to work remotely. I  have to say that the staff has really stepped up the pace and have been even  more productive— if that's possible—than what we've been in the past in response  to patient needs and member needs. 
You know, some of the things we've done  are to put together a lot of very good in-depth information surrounding  COVID-19 patients and put that out free of charge to everyone— effective  therapies for treating a hospitalized patient, a patient at home all the way up  to a patient in an ICU on a ventilator. We've produced a lot of good  information in response to member and patient needs on how to develop field  hospitals. 
As you know, and everyone knows, we  produce a lot of very excellent material to prepare pharmacists for board  certification in order to recertify. One of the information sources that we  prepare and have prepared for a long time is in relation to getting board  certified as a critical care pharmacist. Early on during the COVID-19 pandemic  a large number of our other pharmacists had to step up and take care of the  surge and increasing number of critical care patients. We decided to make those  critical care, preparatory educational resources free to anyone who wants them.
 I can tell you, Tom, the response was  overwhelming. We had 40,000 new people sign up to receive critical care  resources at no cost. So those are a couple of examples of the things that  we've done in the last several months. 
We have also greatly stepped up our  advocacy efforts with the FDA, with CMS, other federal agencies in Congress, to  help get them to expand the roles of pharmacists. Now, this is important  expanding roles of pharmacists to care for COVID-19 patients, but also looking  at expanding roles and the practice of pharmacy into the future that would  apply to all patients. 
I hope I'm answering your question, but  those are few of the things that we've done in efforts to react to a crisis  situation in this country and help prepare our members to better care for their  patients. 
Tom  Johnson: Personally, in our own health system, we  weren't quite sure what we were going to see in terms of surges of patients.  And now of course, we're recording this in the middle of July and certainly  case numbers are increasing in many parts of the country locally. We haven't  had as many, but obviously it tends to be more of a local outbreak type of  disease state. 
I certainly have encouraged our staff  in our health system to take advantage of those educational opportunities. I've  heard great things, nothing but positive comments. 
I think it's a great illustration of  why professional organizations are so important to be a part of. Sometimes I  tend to challenge residents each year as I'm working with them to say, well, I  want you to kind of write down what it is that you're going to get from a  professional organization and what you're going to contribute to professional  organization that you might want to join. Specifically, what are you going to  do with that particular organization? 
Almost universally, what I find is that  we get into discussions about things they've just never really thought of as to  why it's important. One of the reasons it's important to be a member and to be  involved is that having that membership base is what allows ASHP to have the  employees to create that kind of resource. And that's a huge component of what  we all need to do as a profession. 
I've given lots of different talks to  residents and other group. Your first step is to simply become a member because  you just never know when you're going to need those resources. By you being a  member of that organization, you can certainly move those things forward. So I  think that's great.
I just have to say thank you to the staff  again and to your leadership, Paul, and the entire group, because what the  staff has been able to do and pull together. I use those documents on a regular  basis myself. I know others do.
 I  know other groups look to ASHP for guidance and resources in order to move  things forward. It's been a great resource and very much appreciate that work.  So thanks for taking the time to go through that. 
Paul  Abramowitz (11:05): Well, thank you, Tom. We know that  pharmacists are drug therapy experts and are absolutely essential members of  every healthcare team, but Tom, how would you describe the components of this  essential role, particularly to the patients and the public? 
Tom  Johnson (11:27): I've been thinking about that quite a  bit. We live in this sound bite kind of world. Even these podcasts are coming  across in about 10- or 15-minute increments. It's a great way to get messages  out, but sometimes the message can get lost.
We as a profession, and I personally,  have to do a better job just spitting it out and having a short version of what  needs to happen. As I move through what I'm starting to call my virtual ASAP  presidency, I try to find some things that resonate with people. 
One of the things that I tell people  about is, every patient gets a med. If you think about that from a health  system standpoint, there are very few patients that come to our services that  do not get medications at some point.
Yes, you might have an initial  physician visit or provider visit and you may not be prescribed a medication  right away, but it's pretty few and far between the patient that doesn't get a  medication. 
So I like to use that to get us  started—every patient gets a med. That's one reason that pharmacy services is  really important. How we provide this. Then we need to start talking about some  of these essential roles. 
We work on drug distribution and  ensuring supply chain integrity. We work on clinical optimization and ensuring  patients get the right meds. This ties back to our mission statement and vision  statement from ASHP is that our goal is that medication use is optimal all of  the time for all of our patients. 
We may never get to it optimal use for  every patient every time, but that's what we're working toward. That's a good  goal to chase. We have to get to that point where we can describe that. 
There are frustrations and every  profession and pharmacy has no shortage of that. That is absolutely the case.  But instead of dwelling on the negative maybe find one cool thing about your  day. Perhaps you helped somebody with his or her diabetes. When they left their  appointment today, they understood their diabetic meds. Hang on to that one  thing you did, or maybe the 10 things you did. If you really start thinking  about it, there's more than one thing that was positive in your day. Actually,  there was probably only one thing that was negative, but that's what you dwell  on. 
Paul  Abramowitz (14:52): So we have to be able to concisely  demonstrate the value we bring to patients’ health and to the healthcare team.  Can you talk a little bit more about the value that we bring? 
Tom  Johnson (15:09): I've talked about and worked with  students and residents and pharmacists and technicians for a long time on how  do you add value? I think each individual needs to understand their value  statement, so to speak and how they provide value to their organization, to the  profession. 
Take a step back and look at the  organizational structure and why complex organizations exist in our economy. I  would argue that healthcare is one of the most complex organizational  structures that you will find anywhere. 
If you look at why they're important  and why they exist, there's additive and exponential value created by the  organizational structure provided by each person doing their job really well  and working together in order to deliver additional value. 
A key element is that if everybody just  goes and does their own individual thing and doesn't contribute broadly to the  organization, then we're all back to just doing individual things. We don't  really gain the power of the organization in order to move things forward. 
Most of us work in very complex  healthcare systems. We work in large healthcare systems. There are a few that  are in very small practices and small facilities, but I would say the majority  are in very large systems and we get efficiency and can provide better and more  affordable care if we really pushed that forward. 
So back to your specifics of what's our  value? Well, we're the medication use experts. We're good at it. Nobody is  better at it than we are. And that's one of the truths that I talked about in  my inaugural address—we bring a unique perspective to the team and if we don't  voice that unique perspective, then it's not going to be there. And it's not  going to add value to that organization. 
We also add a direct conversation with  a patient that other healthcare professionals aren't going to have, probably  because they're just not as interested in that particular specific area or they  don't have quite the same skillset. 
It's not that they can't, it's just  coming from a different angle. From my time I've spent the better part of 15  years in the ICU, I can look at a chest X Ray and kind of know what's going on,  but I couldn't really intelligently talk with a patient about that. The inverse  might be someone that's really good at looking at that chest X Ray might not be  able to have the same conversation about the unique aspects of the different  quinolones in therapy and why it would be different and translate that to a  patient. 
Coming at it from different  perspectives, we need to be really solid in understanding that value and not  being afraid to move that forward and to tell other people about that. 
Paul  Abramowitz (18:10): Something that I know we all as  pharmacy professionals struggle with, particularly in the area of ensuring  patient safety, is that we oftentimes always try to be perfect. And that's  good. How do we ensure that attempting to be perfect doesn't become the enemy  of being better?
Tom  Johnson (18:46): Yeah, that's a great point, Paul. We  need to be as close to perfection as we can get in a lot of situations in our  profession. For example, chemotherapy is a pretty exact science. We need to be  at a pretty exact dose. 
I think understanding where to apply  that perfection issue is really the component we need to work on. I used to  tell students all the time that they were not going to get a very good grade if  they gave me a creatinine clearance that had three or four decimal places on it  when they estimated it from data that was just not that precise. Yes, your  calculator will get you to four decimal places, but that's not accurate. It's  precise, but it's not that accurate. We need to understand the difference and  know when to apply that dichotomy of perfection and when you need to have which  one. 
There's that law of diminishing returns  that I can work on a project literally forever. I can continue to edit and  continue to move through. And probably what will happen is that variables will  change and I'll have to go back and redo it. And we just can't do that. So I  think that that's a place to find balance for us. 
We need to have that conversation  within the profession, within ASHP, within strategies that we're doing within  our own departments and understand how we need to move forward, and when it's  okay to move forward quickly—when we need to think about it some more and that  it's okay to more of a consensus in a middle ground. So to me, it's that  dichotomy 
Paul  Abramowitz (21:12): Tom, one of the reasons that I think  you're inaugural theme of transformation is so, if I were to use a British  term, “on spot,” is that each one of us is facing some sort of the  transformation at any given moment. 
Now we've already talked a lot about  how ASHP is committed to supporting pharmacy professionals advancing the  profession in this era of COVID change and transformation. Is there anything  else you'd like to add about how ASHP is supporting our members in today's  ever-changing healthcare landscape? 
Tom  Johnson (21:50): Well, I think one of the big things is  understanding your own professional journey. It’s an important component of  what you need to do as an individual and what we need to do as a profession. Sometimes  you just have to go look for the resources that are available. Sometimes you  have to challenge yourself with how you've always done something and see what  else might be out there. 
I am the president of ASHP, and yet  every time I go to the website, I find something else I didn't know it was  there. I need to continually strive to keep getting better, to learn about  what's available, and to find things like certificate programs and  publications, virtual meetings, and how I can be better involved in advocacy. 
I can't do all of those things every  day, but I can do pieces of those and continue to look for them and try to get  a little bit better. I think that's an important message for everybody to just  think about is what are some of those resources are and just go looking for  them. They're probably out there. 
Paul  Abramowitz (23:36): Thanks Tom. Those are great points. You  know, we've talked about how we're in this changing environment and some might  say there is a need for a new normal. With your discussion of transformation, I  think you were a little prophetic when you decided to come up with that topic  before a number of these things were beginning to happen. I just might say that  ASHP is going to weave transformation into everything that we do. 
We've formed our diversity task force  and our efforts for innovating pharmacy through PAI 2030. We’re going to take  looking at things in different ways from simply the basics of how we hold  meetings, whether they need to be virtual—and not just can we make them  virtual, but how can we transform a virtual meeting, start from scratch, and  make it into an exceptional experience. It's different from anything we've ever  had. 
I would like to ask you to comment,  freeform a little bit on anything you would like to add in and around  transformation in ASHP. 
Tom  Johnson (25:09): Thanks, Paul. You know, I'm already  trying to figure out how I get invites to all of the meetings so that I can  sort of pop in and listen virtually to all of these different things. I think  that transformation component, the theme of transformation is one that humans  strive for all the time. It's how we tell stories. There's interesting  components of, if you look at different cultures and how they tell stories,  there is almost always a reluctant hero with a guide who is working through a  challenge and trying to get to a transformation so that they're a better  person. That is almost without exception how effective stories are told. 
Amazingly enough, that comes from cultures  that were separated by distance and really didn't interact with each other. I think  transformation really becomes a human element in something we're looking for  and sometimes changes get forced upon us. Sometimes we're the reluctant heroes  and we need to find a guide and we need to figure out how to truly transform so  that we come out better on the other side. 
That's really where we are. We all can  individually identify with being the reluctant hero. We can probably identify  with being the guide. I don't think any of us would have chosen to go through  this COVID pandemic, but here we are and we've had to figure it out. 
And we've all individually and  collectively been the reluctant heroes. There've been guides available for us  as ASHP has been a guide. I've certainly had my own mentors and in working  through that process and trying to figure out the best way to go, but that's  what we'll be doing. 
I think transformation is going to be  our theme. How do we come through this and be better for it, even though we're  a little reluctant. How do we work our way through and how do we come out  better as a profession, as individuals, and as an organization. 
So there's my freeform answer for you,  Paul. That's what I got today. 
Paul  Abramowitz: Thank you, Tom. Well, unfortunately,  that's all we have time for today. Thank you Tom, for sharing your thoughts and  insights about how transformation creates new opportunities. And again, I'd  encourage everyone to read Tom's inaugural address. You can find it on  ashp.org. Join us next time for our final episode of Truth in Transformation when we'll conclude our conversations about  transformation with learning how to act on our truth.